Pharmaron Beijing (03759) granted a total of approximately 3.5336 million H-share awards.

Pharmaron Beijing (03759) announced that on September 18, 2026, the 2025 H-Share Plan Management Committee resolved to grant a total of approximately 2.0422 million H-share awards to 221 employees under the 2025 H-Share Plan. On September 18, 2026, the 2026 H-Share Plan Management Committee resolved to grant a total of approximately 1.4915 million H-share awards to 86 employees under the 2026 H-Share Plan. The purpose of this grant is: to attract, motivate and retain highly skilled and experienced talent by providing eligible persons with the opportunity to hold equity interests in the Company, and to strive to promote the future development and expansion of the Group; to recognize the contributions of the grantees to the Company; to encourage, motivate and retain the grantees so that they continue to contribute to the operation, development and long-term growth of the Group; and to align the interests of the grantees with those of the shareholders and the Group as a whole, and to provide additional incentives to the grantees.